Skip to menu Skip to content Skip to footer

2012

Journal Article

Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics

Abdul-Aziz, Mohd Hafiz, Staatz, C. E., Kirkpatrick, C. M. J., Lipman, J. and Roberts, J. A. (2012). Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics. Minerva Anestesiologica, 78 (1), 94-104.

Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics

2012

Journal Article

Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation

Bergmann, Troels K., Barraclough, Katherine A., Lee, Katie J. and Staatz, Christine E. (2012). Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation. Clinical Pharmacokinetics, 51 (11), 711-741. doi: 10.1007/s40262-012-0007-8

Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation

2011

Journal Article

Population pharmacokinetics of tacrolimus in pediatric liver transplantation: Early posttranplantation clearance

Wallin, Johan E., Bergstrand, Martin, Wilczek, Henryk E., Nydert, Per S., Karlsson, Mats O. and Staatz, Christine E. (2011). Population pharmacokinetics of tacrolimus in pediatric liver transplantation: Early posttranplantation clearance. Therapeutic Drug Monitoring, 33 (6), 663-672. doi: 10.1097/FTD.0b013e31823415cc

Population pharmacokinetics of tacrolimus in pediatric liver transplantation: Early posttranplantation clearance

2011

Journal Article

Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?

Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000

Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?

2011

Journal Article

Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients

Barraclough, Katherine A, Isbel, Nicole M., McWhinney, Brett C., Ungerer, Jacobus P. J., Medley, Gregory, Johnson, David W., Hawley, Carmel M., Leary, Diana R., Campbell, Scott B. and Staatz, Christine E. (2011). Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. European Journal of Clinical Pharmacology, 67 (12), 1243-1252. doi: 10.1007/s00228-011-1071-y

Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients

2011

Journal Article

Once- versus twice-daily tacrolimus: Are the formulations truly equivalent?

Barraclough, Katherine A, Isbel, Nicole M., Johnson, David W., Campbell, Scott B. and Staatz, Christine E. (2011). Once- versus twice-daily tacrolimus: Are the formulations truly equivalent?. Drugs, 71 (12), 1561-1577. doi: 10.2165/11593890-000000000-00000

Once- versus twice-daily tacrolimus: Are the formulations truly equivalent?

2011

Journal Article

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

Tett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

2011

Journal Article

Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients

Barraclough, KA, Isbel, NM, Kirkpatrick, CM, Lee, KJ, Taylor, PJ, Johnson, DW, Campbell, SB, Leary, DR and Staatz, CE (2011). Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients. British Journal of Clinical Pharmacology, 71 (2), 207-223. doi: 10.1111/j.1365-2125.2010.03815.x

Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients

2011

Journal Article

BK virus in kidney transplant recipients: The influence of immunosuppression

Barraclough, Katherine A, Isbel, Nicole M., Staatz, Christine E. and Johnson, David W. (2011). BK virus in kidney transplant recipients: The influence of immunosuppression. Journal of Transplantation, 2011 (1) 750836, Article ID 750836-9. doi: 10.1155/2011/750836

BK virus in kidney transplant recipients: The influence of immunosuppression

2010

Journal Article

Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients

Barraclough, Katherine A., Isbel, Nicole M., Franklin, Michael E., Lee, Katie J., Taylor, Paul J., Campbell, Scott B., Petchey, William G. and Staatz, Christine E. (2010). Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients. Therapeutic Drug Monitoring, 32 (6), 723-733. doi: 10.1097/FTD.0b013e3181fc8fbb

Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients

2010

Journal Article

Pharmacodynamic monitoring of immunosuppression in kidney transplantation

Barraclough, Katherine A., Staatz, Christine E., Isbel, Nicole M. and McTaggart, Steven J. (2010). Pharmacodynamic monitoring of immunosuppression in kidney transplantation. Nephrology, 15 (5), 522-532. doi: 10.1111/j.1440-1797.2010.01349.x

Pharmacodynamic monitoring of immunosuppression in kidney transplantation

2010

Journal Article

Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and opticept trials

Barraclough, KA, Isbel, NM and Staatz, CE (2010). Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and opticept trials. Transplantation, 90 (1), 44-51. doi: 10.1097/TP.0b013e3181e06584

Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and opticept trials

2010

Journal Article

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

Staatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II. Clinical Pharmacokinetics, 49 (4), 207-221. doi: 10.2165/11317550-000000000-00000

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

2010

Journal Article

Pharmacogenetic influences on mycophenolate therapy

Barraclough, Katherine A., Lee, Katie J. and Staatz, Christine E. (2010). Pharmacogenetic influences on mycophenolate therapy. Pharmacogenomics, 11 (3), 369-390. doi: 10.2217/PGS.10.9

Pharmacogenetic influences on mycophenolate therapy

2010

Journal Article

Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation

Kuypers, Dirk R. J., Le Meur, Yannick, Cantarovich, Marcel, Tredger, Michael J., Tett, Susan E., Cattaneo, Dario, Tonshoff, Burkhard, Holt, David W., Chapman, Jeremy, van Gelder, Teun, for The Transplantation Society (TTS) Consensus Group on TDM of MPA and Staatz, Christine E. (2010). Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clinical Journal of the American Society of Nephrology, 5 (2), 341-358. doi: 10.2215/CJN.07111009

Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation

2010

Journal Article

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I

Staatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clinical Pharmacokinetics, 49 (3), 141-175. doi: 10.2165/11317350-000000000-00000

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I

2009

Journal Article

Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: New initial dosage suggestions and a model-based dosage adjustment tool

Wallin, Johan E., Friberg, Lena E., Fasth, Anders and Staatz, Christine E. (2009). Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: New initial dosage suggestions and a model-based dosage adjustment tool. Therapeutic Drug Monitoring, 31 (4), 457-466. doi: 10.1097/FTD.0b013e3181aab02b

Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: New initial dosage suggestions and a model-based dosage adjustment tool

2009

Journal Article

A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme

Staatz, Christine E., Smith, Alesha J. and Tett, Susan E. (2009). A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme. Pharmacoepidemiology and drug safety, 18 (5), 386-392. doi: 10.1002/pds.1726

A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme

2009

Journal Article

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

Barraclough, K.A., Staatz, C.E., Isbel, N.M. and Johnson, D.W. (2009). Therapeutic monitoring of mycophenolate in transplantation: Is it justified?. Current Drug Metabolism, 10 (2), 179-187. doi: 10.2174/138920009787522205

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

2009

Journal Article

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations

Thomson, A. H., Staatz, C. E., Tobin, C. M., Gall, M. and Lovering, A. M. (2009). Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. Journal of Antimicrobial Chemotherapy, 63 (5), 1050-1057. doi: 10.1093/jac/dkp085

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations